
Please try another search
Name | Net % | Long % | Short % |
---|---|---|---|
Cash | 1.540 | 1.650 | 0.110 |
Shares | 98.460 | 98.460 | 0.000 |
Ratios | Value | Category Average |
---|---|---|
P/E Ratio | 18.593 | 18.205 |
Price to Book | 3.255 | 3.041 |
Price to Sales | 2.883 | 2.237 |
Price to Cash Flow | 13.285 | 12.229 |
Dividend Yield | 1.901 | 2.036 |
5 Years Earnings Growth | 13.175 | 10.536 |
Name | Net % | Category Average |
---|---|---|
Financial Services | 19.610 | 16.790 |
Industrials | 18.470 | 11.567 |
Healthcare | 16.490 | 13.068 |
Technology | 15.580 | 23.730 |
Basic Materials | 7.590 | 3.965 |
Consumer Defensive | 7.530 | 7.498 |
Consumer Cyclical | 7.280 | 10.618 |
Communication Services | 6.390 | 7.908 |
Real Estate | 1.070 | 2.745 |
Number of long holdings: 87
Number of short holdings: 1
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Visa A | US92826C8394 | 3.16 | 331.40 | +3.53% | |
Charles Schwab | US8085131055 | 2.84 | 76.58 | +2.17% | |
Schneider Electric | FR0000121972 | 2.53 | 199.60 | -2.78% | |
Microsoft | US5949181045 | 2.44 | 366.82 | +2.14% | |
Willis Towers Watson | IE00BDB6Q211 | 2.40 | 324.69 | +2.83% | |
Medtronic | IE00BTN1Y115 | 2.31 | 83.37 | +1.92% | |
Alphabet A | US02079K3059 | 2.17 | 151.47 | +2.57% | |
Honeywell | US4385161066 | 2.15 | 198.45 | +2.17% | |
Thermo Fisher Scientific | US8835561023 | 2.07 | 434.70 | +3.05% | |
Comcast | US20030N1019 | 2.07 | 34.17 | +1.70% |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
MFS Global Equity Fund TUKGBP | 404.41M | -1.54 | 3.54 | 8.92 | ||
MFS Global Concentrated Equity Fucg | 114.58M | -0.82 | 3.71 | 9.60 |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review